These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31464104)

  • 1. Evaluation of SOX2 and podoplanin expression in oral epithelial dysplasia and its correlation with malignant transformation.
    Verma V; Chandrashekar C
    J Investig Clin Dent; 2019 Nov; 10(4):e12450. PubMed ID: 31464104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the co-expression of SOX2 and Podoplanin in the progression of oral squamous cell carcinomas - an immunohistochemical study.
    Pradhan S; Guddattu V; Solomon MC
    J Appl Oral Sci; 2019 Sep; 27():e20180348. PubMed ID: 31508790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
    D'souza B; Nayak R; Kotrashetti VS
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
    Vijayakumar G; Narwal A; Kamboj M; Sen R
    Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin expression in oral leukoplakia: tumorigenic role.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin expression in oral leukoplakia─a prospective study.
    Grochau KJ; Safi AF; Drebber U; Grandoch A; Zöller JE; Kreppel M
    J Craniomaxillofac Surg; 2019 Mar; 47(3):505-509. PubMed ID: 30638740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of podoplanin in potentially malignant disorders and oral squamous cell carcinoma and its correlation with lymphangiogenesis.
    Parhar S; Kaur H; Vashist A; Verma S
    Indian J Cancer; 2015; 52(4):617-22. PubMed ID: 26960495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia.
    Monteiro L; do Amaral B; Delgado L; Garcês F; Salazar F; Pacheco JJ; Lopes C; Warnakulasuriya S
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
    Shi P; Liu W; Zhou ZT; He QB; Jiang WW
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of podoplanin expression to histopathological grades of oral epithelial dysplasia and oral squamous cell carcinoma.
    Shabir H; Durrani SH; Tariq SF; Khatak SS; Khan AS; Arbab KN
    J Pak Med Assoc; 2024 May; 74(5):852-856. PubMed ID: 38783429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression as a predictive marker of dysplasia in oral leukoplakia.
    Gissi DB; Gabusi A; Tarsitano A; Luccarini L; Morandi L; Montebugnoli L
    J Craniomaxillofac Surg; 2018 May; 46(5):759-764. PubMed ID: 29588189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
    Saigusa S; Mohri Y; Ohi M; Toiyama Y; Ishino Y; Okugawa Y; Tanaka K; Inoue Y; Kusunoki M
    Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podoplanin Expression Is Correlated With the Progression of Chronic Discoid Lupus Erythematosus to Lip Squamous Cell Carcinoma.
    Gao X; Ma L; Zhou Z; Jian X; Liu W
    Int J Surg Pathol; 2016 Oct; 24(7):595-9. PubMed ID: 27240861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer.
    Barros FBA; Assao A; Garcia NG; Nonogaki S; Carvalho AL; Soares FA; Kowalski LP; Oliveira DT
    BMC Cancer; 2018 Jan; 18(1):53. PubMed ID: 29310601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
    Zhang G; Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
    Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
    J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podoplanin expression in oral leukoplakia: prognostic value and clinicopathological implications.
    Kreppel M; Kreppel B; Drebber U; Wedemayer I; Rothamel D; Zöller JE; Scheer M
    Oral Dis; 2012 Oct; 18(7):692-9. PubMed ID: 22471854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma.
    A G D; Janardanan-Nair B; B R V
    J Clin Exp Dent; 2017 Dec; 9(12):e1418-e1424. PubMed ID: 29410757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.